Macrophage-Based Approaches for Cancer Immunotherapy

Area of Science:

• Immunology
• Oncology
• Cell Therapy

Background:

• Adoptive T cell therapy shows success in blood cancers but struggles with solid tumors.
• Macrophages exhibit functional plasticity, contributing to both anti-tumor and pro-tumor activities.
• Current strategies involve depleting or repolarizing tumor-associated macrophages.

Purpose of the Study:

• To review the role of macrophages in solid tumors.
• To discuss progress in macrophage-focused immunotherapies.
• To introduce chimeric antigen receptor macrophage (CAR-M) cell therapy.

Main Methods:

• Literature review of macrophage roles in solid tumors.
• Analysis of existing immunotherapeutic strategies targeting macrophages.
• Exploration of the potential of ex vivo genetically modified macrophages.

Main Results:

• Macrophages are key players in the tumor microenvironment of solid tumors.
• Various immunotherapeutic approaches targeting macrophages are under investigation.
• Chimeric antigen receptor macrophage (CAR-M) therapy is an emerging modality.

Conclusions:

• Macrophages present a viable alternative cell type for adoptive cell therapy in solid tumors.
• Genetic modification of macrophages, particularly with CARs, holds significant therapeutic potential.
• CAR-M therapy represents a novel frontier in solid tumor immunotherapy.